Clinical Trials
3 trialsNCT07343401 2026-01-15
Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development
Alexandria University
Completed
NCT01649791 2016-06-30
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
Phase NA Terminated
NCT00621452 2014-08-06
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
Phase 1 Completed